Evidence map›Paper›PMID 39338356›Full record

ArticlePharmaceuticals (Basel, Switzerland)2024

Alena Špičáková, Zuzana Horáčková, Pavel Kopel, Pavel Anzenbacher

Abstract read
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Alena ŠpičákováDepartment of Pharmacology, Faculty of Medicine, Palacký University Olomouc, Hněvotínská 3, 779 00 Olomouc, Czech Republic.ORCID 0000-0003-0239-1300
Zuzana HoráčkováLaboratory of Growth Regulators, Faculty of Science, Palacký University & Institute of Experimental Botany of the Czech Academy of Sciences, Šlechtitelů 27, 78 371 Olomouc, Czech Republic.
Pavel KopelDepartment of Inorganic Chemistry, Faculty of Science, Palacký University Olomouc, 17. Listopadu 1192/12, 779 00 Olomouc, Czech Republic.ORCID 0000-0003-4216-9544
Pavel AnzenbacherDepartment of Pharmacology, Faculty of Medicine, Palacký University Olomouc, Hněvotínská 3, 779 00 Olomouc, Czech Republic.ORCID 0000-0001-5904-337X

Funding

Internal Grants of Palacký University IGA_LF_2024_006 and IGA_PrF_2024_013
6 · The paper itself

Abstract

Two copper(II) mixed ligand complexes with dicarboxylate bridges were prepared and studied, namely [Cu

Indexed as

antibacterial activitycopper complexescytochromes P450dicarboxylic aciddrug interactionsenzyme activityinhibition

Identifiers

PMID39338356
PMCPMC11434749

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.